Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Both azathioprine and betamethasone treatments effectively regrow hair in alopecia areata, but azathioprine may be safer.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Advanced delivery systems can make dithranol more effective and less irritating for treating psoriasis.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Early diagnosis, intensive therapy, and careful follow-up are crucial for managing overlapping TTP and SLE.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Stopping TNFα inhibitors can help children regrow hair lost due to the medication.

AHST shows promise for treating type 1 diabetes but needs more research before widespread use.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Vitiligo treatment is improving with new drugs and therapies, focusing on personalized and combined approaches.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.